The Incubator

Startup Sioux Falls graduates second CO.STARTERS cohort

Graduation Day has come! Meet the entrepreneurs who now have completed the CO.STARTERS program.

5 years ago

Sanford doctor’s device simplifies lung blood clot treatment

Sanford Health vascular surgeon Dr. Patrick Kelly has invented a unique device to transform treatment of blood clots in the lungs that kill as many as 100,000 Americans each year.

5 years ago

SAB Biotherapeutics doses first patient in next phase of trial for influenza treatment

SAB Biotherapeutics is moving ahead with clinical trials for its influenza treatment.

5 years ago

CO.STARTERS participants tout value accountability, connections

We love getting to know new businesses! Meet three who are finding lots of value participating in the Startup Sioux Falls CO.STARTERS program.

5 years ago

At Sanford Underground Research Facility, international-level experiments create big state impact

South Dakota is preparing to host one of the largest science experiments ever attempted on U.S. soil – underground. Come with us for a look at what’s happening at the Sanford Underground Research Facility.

5 years ago

SAB Biotherapeutics to trade on Nasdaq following merger

Sioux Falls-based SAB Biotherapeutics plans to merge with a Miami-based firm, which will allow it to trade on the Nasdaq.

5 years ago

Get connected to growing biotech scene at upcoming event

Bioscience education, research and development didn’t stop in 2020 – and this is your chance to catch up on what has been happening.

5 years ago

USD Discovery District looks to start first building

A building that would house multiple biotech companies is envisioned as a catalyst to draw more activity to the USD Discovery District.

5 years ago

Local startup Helen’s Plan looks to expand reach through strategic partnerships

Great traction: A Sioux Falls startup has a new partnership with a national senior care provider.

5 years ago

SAB Biotherapeutics takes another big step with COVID-19 therapeutic

SAB Biotherapeutics’ therapeutic for COVID-19 could help target variants and is entering a new stage of testing. And that’s far from the company’s only development.

5 years ago

News Tip

Have a business news item to share with us?

Scroll to top